Wednesday, March 01, 2023 11:34:06 AM
VIA ECF
Hon. Gabriel W. Gorenstein United States Magistrate Judge United States District Court Southern District of New York 500 Pearl St.
WRITER’S DIRECT DIAL NO.
(202) 538-8120
WRITER’S EMAIL ADDRESS
williamburck@quinnemanuel.com
MEMORANDUM ENDORSED
New York, NY 10007-1312
Re: Northwest Biotherapeutics Inc. v. Canaccord, et al., No. 1:22-cv-10185-GHW-GWG Dear Judge Gorenstein:
We represent Defendant Citadel Securities LLC (“Citadel Securities”) in the above- captioned action and also write on behalf of co-Defendants Canaccord Genuity LLC, G1 Execution Services LLC, GTS Securities LLC, Instinet LLC, Lime Trading Corp., Susquehanna International Group LLP (“SIG”),1 and Virtu Americas LLC to respectfully request a 30-day extension of the deadline to respond to the Complaint, from March 6, 2023 to April 5, 2023.
By way of background, this case concerns allegations that Defendants each—separately and without coordinating their activities—manipulated the market for Plaintiff Northwest BiotherapeuticsInc.’s(“NWBO”)stockthrough“spoofing.” See,e.g.,Compl.¶7. OnFebruary 23, 2023, having investigated the allegations in NWBO’s 281-paragraph Complaint, Defendants informed NWBO of material objective factual inaccuracies in NWBO’s trading allegations, specifically with respect to NWBO’s data. In their February 23 letter, Defendants explained that Citadel Securities and other Defendants would provide further information to NWBO concerning thesignificanterrorsintheallegationsagainstthem. DefendantsrequestedNWBO’spositionon a 30-day extension of time to respond to the Complaint—which would permit NWBO to evaluate this information and determine whether to withdraw the Complaint—no later than 5 pm ET on February 27.
1
contains no substantive allegations regarding trading or “spoofing” by SIG.
SIG joins this letter to propose a consolidated briefing schedule only, and notes that the Complaint
quinn emanuel urquhart & sullivan, llp
ATLANTA | AUSTIN | BERLIN | BOSTON | BRUSSELS | CHICAGO | DALLAS | DOHA | HAMBURG | HONG KONG | HOUSTON | LONDON | LOS ANGELES | MANNHEIM | MIAMI | MUNICH | NEUILLY-LA DEFENSE | NEW YORK | PARIS | PERTH | RIYADH | SALT LAKE CITY | SAN FRANCISCO | SEATTLE | SHANGHAI | SILICON VALLEY | STUTTGART | SYDNEY | TOKYO | WASHINGTON, DC | ZURICH
Case 1:22-cv-10185-GHW-GWG Document 779 Filed 02/278/23 Page 2 of 2
On February 26, at NWBO’s request, Citadel Securities provided NWBO with detailed descriptions of some of the factual inaccuracies, which materially impact NWBO’s claims and allegationsagainstCitadelSecurities. Theletter,asacourtesy,attachedaccuratetradingdatafrom OTC Link, the platform on which Citadel Securities trades NWBO and the original source for such trading information. See Ltr. from W. Burck to L. Posner, Feb. 26, 2023, attached as Exhibit A. Citadel Securities provided NWBO with this information as a courtesy to assist it in determining whether to object to Defendants’ requested extension, and the information was provided without prejudice to service of a potential motion for Rule 11 sanctions, which Citadel Securities intends to serve by March 8, 2023, if the Complaint is not withdrawn.
Defendants respectfully request the instant 30-day extension of time to respond to the Complaint—which will not change any other scheduled deadlines—so that NWBO will have sufficient time to determine whether to withdraw the Complaint, including 21 days after service ofanyRule11motion. Thiswillallowthepartiestoavoidmovingforwardwithmotiontodismiss briefingthatmayotherwisebecomemoot(giventhatmanyofthefactualallegationstheComplaint reliesuponareutterlywrong). Therequestedextensionwillthusconservejudicialresourcesand promote efficiency, and the brief delay will not cause any meaningful prejudice to NWBO.
Although NWBO responded to Defendants’ February 23 letter to request additional information concerning the errors in NWBO’s Complaint, and Citadel Securities provided that information on February 26, NWBO has not taken any position on Defendants’ extension request. This is Defendants’ second request for extension of time to respond to the Complaint; Defendants previously requested an adjournment because, among other reasons, NWBO had not yet effected service on all Defendants.
Defendants therefore respectfully request that the March 6, 2023 deadline to respond to the Complaint be extended 30 days to April 5, 2023. To the extent NWBO elects not to withdraw the Complaint, Defendants intend to meet and confer with NWBO concerning a briefing schedule for motions to dismiss.
Respectfully submitted,
/s/ William Burck
William Burck
Granted in part and denied in part. In light of plaintiff’s response, an extension is granted only until March 20, 2023. If both parties agree to a further extension, it may be requested by means of a letter compliant with paragraph 1.E of the Court’s Individual Practices. On a separate point, the Court wishes to be sure that the memoranda of law are properly focused. Accordingly, the parties shall be limited to 25 pages for any moving and opposition brief and to 15 pages for any reply brief.
So Ordered.
February 28, 2023
2
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM